During regular trading hours, there were many stocks that continued to break up to the upside. These stocks are usually going up with news.If you are looking to day trade also check out my Top 2011 Stock Gainers , Stocks to Buy 2012.You can also check previous stocks to buy reports- Right Here today.Hot stocks Today Right Here.I also have technical analysis different stocks-Right Here. Market Technical analysis Right Here
Quick Look Market Closing Price:
At the close: Dow +1.06% to 12587. S&P +1.2% to 1334. Nasdaq +1.18% to 2871.
Treasurys: 30-year +0.01%. 10-yr -0.05%. 5-yr -0.03%.
Commodities: Crude -0.05% to $90.81. Gold -0.88% to $1557.45.
Currencies: Euro -0.34% vs. dollar. Yen +0.07%. Pound +0.29%.
After Hours News:
Pandora Media Inc. (NYSE:P) is currently trading at $11.79 up 11.3% in after-hours on 18320 shares traded.
Repros Therapeutics (RPRX) says the FDA has advised the company it must complete an integrated safety analysis of completed studies of oral Proellex. Once completed, the report must be submitted to the FDA for review prior to any additional oral trials. Shares -5.6% AH
Perfect World (PWRD): Q1 EPS of $0.72 misses by $0.01. Revenue of $114.1M (+3% Y/Y) misses by $2.8M. Shares -14.8% AH.
DryShips (DRYS): Q1 EPS of -$0.11 misses by $0.06. Revenue of $247.5M (+19% Y/Y) misses by $20M. Shares -3.1% AH.
Synergetics (SURG) -8.8% AH after issuing downside FQ3 guidance, seeing EPS of $0.04-$0.06 vs. $0.08 consensus and revenues of $14.4M-$14.7M vs. $16.25M consensus; ophthalmic sales are expected to drop ~9% Y/Y. SURG cites difficulties in Europe, which is depressing demand for ophthalmic disposables and exerting an unfavorable foreign currency impact .
Research In Motion (RIMM) has resumed trading, and is now down 11.2% AH, making new multi-year lows in the process. With rumors already in place about the hiring of strategic advisers, and a sale not mentioned among the options RIM claims JPMorgan and RBC will advise on, investors are focusing on RIM's guidance for an FQ1 loss.
Repros Therapeutics (RPRX) says the FDA has advised the company it must complete an integrated safety analysis of completed studies of oral Proellex. Once completed, the report must be submitted to the FDA for review prior to any additional oral trials. Shares -5.6% AH
Perfect World (PWRD): Q1 EPS of $0.72 misses by $0.01. Revenue of $114.1M (+3% Y/Y) misses by $2.8M. Shares -14.8% AH.
DryShips (DRYS): Q1 EPS of -$0.11 misses by $0.06. Revenue of $247.5M (+19% Y/Y) misses by $20M. Shares -3.1% AH.
Synergetics (SURG) -8.8% AH after issuing downside FQ3 guidance, seeing EPS of $0.04-$0.06 vs. $0.08 consensus and revenues of $14.4M-$14.7M vs. $16.25M consensus; ophthalmic sales are expected to drop ~9% Y/Y. SURG cites difficulties in Europe, which is depressing demand for ophthalmic disposables and exerting an unfavorable foreign currency impact .
Research In Motion (RIMM) has resumed trading, and is now down 11.2% AH, making new multi-year lows in the process. With rumors already in place about the hiring of strategic advisers, and a sale not mentioned among the options RIM claims JPMorgan and RBC will advise on, investors are focusing on RIM's guidance for an FQ1 loss.
For the latest updates on the stock market, visit,
http://daytradingstock-blog.blogspot.com/
